Zobrazeno 1 - 10
of 145
pro vyhledávání: '"Yi-Hsin Weng"'
Autor:
Ching-Chi Chiu, Ying-Ling Chen, Yi-Hsin Weng, Shu-Yu Liu, Hon-Lun Li, Tu-Hsueh Yeh, Hung-Li Wang
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 12, p 6711 (2024)
A homozygous mutation of the DNAJC6 gene causes autosomal recessive familial type 19 of Parkinson’s disease (PARK19). To test the hypothesis that PARK19 DNAJC6 mutations induce the neurodegeneration of dopaminergic cells by reducing the protein exp
Externí odkaz:
https://doaj.org/article/e27b9ebed4154171be620d8460ddc373
Autor:
Chih-Chien Tsai, Yao-Liang Chen, Chin-Song Lu, Jur-Shan Cheng, Yi-Hsin Weng, Sung-Han Lin, Yi-Ming Wu, Jiun-Jie Wang
Publikováno v:
Biomedical Journal, Vol 46, Iss 3, Pp 100541- (2023)
Background: There are currently no specific tests for either idiopathic Parkinson’s disease or Parkinson-plus syndromes. The study aimed to investigate the diagnostic performance of features extracted from the whole brain using diffusion tensor ima
Externí odkaz:
https://doaj.org/article/07886cde15d14782ae6c68ab081c32a8
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
IntroductionREM Sleep Behavior Disorder (RBD) has been highlighted to identify a patient with prodromal Parkinson’s disease (PD). Although many studies focus on biomarkers to predict an RBD patient’s evolution from prodromal PD to clinical PD, th
Externí odkaz:
https://doaj.org/article/0fde8668dfd241dd8583f9a58897d9fe
Autor:
Yi-Chieh Chen, Rou-Shayn Chen, Yi-Hsin Weng, Ying-Zu Huang, Chiung Chu Chen, June Hung, Yi-Ying Lin
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Nonmotor symptoms (NMSs) cause major burden in patients with Parkinson’s disease (PD). Previous NMSs progression studies mostly focused on the prevalence. We conducted a longitudinal study to identify the progression pattern by the severit
Externí odkaz:
https://doaj.org/article/a83974dd6d764def83552558164d2688
Publikováno v:
Frontiers in Nutrition, Vol 8 (2021)
Background:Lactobacillus plantarum PS128 (PS128) is a specific probiotic, known as a psychobiotic, which has been demonstrated to alleviate motor deficits and inhibit neurodegenerative processes in Parkinson's disease (PD)-model mice. We hypothesize
Externí odkaz:
https://doaj.org/article/f55e888377044297a2877552dc0999c9
Autor:
Thanh-Thao Nguyen, Jur-Shan Cheng, Yao-Liang Chen, Yu-Chun Lin, Chih-Chien Tsai, Chin-Song Lu, Yi-Hsin Weng, Yi-Ming Wu, Ngoc-Thanh Hoang, Jiun-Jie Wang
Publikováno v:
Frontiers in Aging Neuroscience, Vol 13 (2021)
Introduction: White matter degeneration may contribute to clinical symptoms of parkinsonism.Objective: We used fixel-based analysis (FBA) to compare the extent and patterns of white matter degeneration in different parkinsonian syndromes—including
Externí odkaz:
https://doaj.org/article/6ae9228fca8040ce9458e2466d2a7b9c
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-10 (2018)
Abstract [18F]9-fluoropropyl-(+)-dihydrotetrabenazine (18F-(+)DTBZ) is a recently developed PET tracer to investigate the vesicular monoamine transporter type 2 (VMAT2) activity in measuring dopaminergic degeneration in vivo and monitoring the severi
Externí odkaz:
https://doaj.org/article/e270606fcffc40d1ab4a338acefae247
Autor:
Ching-Chi Chiu, Hung-Li Wang, Yi-Hsin Weng, Rou-Shayn Chen, Chiung-Mei Chen, Tu-Hsueh Yeh, Chin-Song Lu, Yu-Jie Chen, Yu-Chuan Liu, Ying-Zu Huang, Kuo-Hsuan Chang
Publikováno v:
Stem Cell Research, Vol 40, Iss , Pp - (2019)
Mutations in PLA2G6 gene cause PLA2G6-associated neurodegeneration, including recessive familial type 14 of Parkinson's disease (PARK14). Previously, we identified PARK14 patients with compound heterozygous c.991G > T/c.1077G > A (p.D331Y/p.M358IfsX)
Externí odkaz:
https://doaj.org/article/2612f947a37e4754ac44cd4e2cd1524f
Autor:
Ching-Chi Chiu, Tu-Hsueh Yeh, Rou-Shayn Chen, Hua-Chien Chen, Ying-Zu Huang, Yi-Hsin Weng, Yi-Chuan Cheng, Yu-Chuan Liu, Ann-Joy Cheng, Ya-Ching Lu, Yu-Jie Chen, Yan-Wei Lin, Chia-Chen Hsu, Ying-Ling Chen, Chin-Song Lu, Hung-Li Wang
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 13 (2019)
MicroRNAs (miRs) downregulate or upregulate the mRNA level by binding to the 3′-untranslated region (3′UTR) of target gene. Dysregulated miR levels can be used as biomarkers of Parkinson’s disease (PD) and could participate in the etiology of P
Externí odkaz:
https://doaj.org/article/99e9643423b2450cac9761d767db081e
Autor:
Jung-Lung Hsu, Shih-Hsin Chen, Ing-Tsung Hsiao, Chin-Song Lu, Tzu-Chen Yen, Nobuyuki Okamura, Kun-Ju Lin, Yi-Hsin Weng
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-2 (2021)
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Externí odkaz:
https://doaj.org/article/b38a5391e0c5447dbdece2a355408c0b